2025-521026-15-00
Not yet recruiting
Phase 1
Personalized Treatment for Endometriosis: A Study on the Safety and Kinetics of Dienogest in Women with Different Gene Variants
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa1 site in 1 country48 target enrollmentStarted: March 18, 2025Last updated:
Overview
- Phase
- Phase 1
- Status
- Not yet recruiting
- Enrollment
- 48
- Locations
- 1
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Gina Paola Mejía Abril
Scientific
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Prediction of Therapy Responde in Endometriosis patientsN80EndometriosisDRKS00021236Klinik für Gynäkologie und GeburtsmedizinRWTH Uniklinik Aachen200
Recruiting
Phase 2
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With EndometriosisNCT07260669Gesynta Pharma AB190
Not yet recruiting
Not Applicable
Impact of Magnetic Stimulation on Pain in Endometriosis PatientsNCT07265687Kantonsspital Winterthur KSW30
Unknown
Phase 4
Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion BarrierEndometriosisNCT02165917Pius-Hospital Oldenburg60
Active, not recruiting
Phase 4
To assess how safe and effective Visanne (Dienogest) is in managing pelvic pain caused due to endometriosisCTRI/2022/04/041870Bayer Pharmaceuticals Pvt Ltd160